📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Immediate versus modified release hydrocortisone in mitotane-treated patients with adrenocortical cancer (2017)

First Author: Weigel M

Attributed to: MICA: Phase II study of the impact of AZD4017 a selective 11beta-HSD1 inhibitor on biochemical markers of bone turnover in post-menopausal osteopaenia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/cen.13302

PubMed Identifier: 28063163

Publication URI: http://europepmc.org/abstract/MED/28063163

Type: Journal Article/Review

Parent Publication: Clinical Endocrinology

Issue: 4

ISSN: 0300-0664